Washington University and Deerfield Management launch VeritaScience to drive drug discovery
Washington University in St. Louis and Deerfield Management, a health-care investment firm, announced the launch of VeritaScience, a new private R&D collaboration designed to advance the discovery, clinical development and commercialization of promising therapeutic and diagnostic candidates with potential to benefit human health.
Awardees announced for Needleman innovation, commercialization program
Three WashU researchers developing promising therapeutics for cancer and heart disease are the inaugural awardees of the Needleman Program for Innovation and Commercialization. The next round of project proposals is now open.
Fehniger receives grant for trial of immunotherapy against melanoma
Todd A. Fehniger, MD, PhD, and colleagues Alice Y. Zhou, MD, PhD, Ryan C. Fields, MD, and George Ansstas, MD, all at the School of Medicine, have received $1.5 million from the Rising Tide Foundation for Cancer Research and the Melanoma Research Alliance.
Metabolism-boosting, bile acid-reducing drugs improve gut health
Researchers at the School of Medicine found that metabolism-boosting, bile acid-reducing drugs improved gut health in mice. The findings indicate a new approach that may help malnourished children with stunted growth.
Study reveals clues to how Eastern equine encephalitis virus invades brain cells
Researchers at the School of Medicine have determined how Eastern equine encephalitis virus attaches to a receptor it uses to enter and infect cells. The findings lay a foundation for treatments and vaccines for viral infections.
Weil receives Kyelem Prize for work on neglected tropical diseases
Gary Weil, MD, a professor of medicine and of molecular microbiology at the School of Medicine, received the 2023 Kyelem Prize at the Coalition for Operational Research on Neglected Tropical Diseases’ annual meeting.
Three receive grant for NK cell-based therapy trial for kids with AML
Todd A. Fehniger, MD, PhD, and co-principal investigators Jeffrey J. Bednarski, MD, PhD, and Thomas Pfeiffer, MD, all at the School of Medicine, have received a total of $1.4 million from the Leukemia & Lymphoma Society, the Rising Tide Foundation for Clinical Cancer Research and Siteman Kids to support a clinical trial of a novel cell-based immunotherapy.
To help advance fight against vision loss, Fort pledges $15 million
Research led by Rajendra S. Apte, MD, PhD, at the School of Medicine, is the focus of a $15 million pledge from philanthropist Jeffrey T. Fort to accelerate research and develop new treatments for diseases that cause vision loss.
‘Long flu’ has emerged as a consequence similar to long COVID
New research from the School of Medicine and the Veterans Affairs St. Louis Health Care System comparing the viruses that cause the flu and COVID-19 shows that people hospitalized with seasonal influenza also can suffer long-term negative health effects.
Kulkarni recognized for research into complement system
Hrishikesh S. Kulkarni, MD, an assistant professor of medicine in the Division of Pulmonary & Critical Care Medicine at the School of Medicine, has received the 2023 Svar Complement Excellence Award from the International Complement Society and life sciences company Svar.
Older Stories